SU5402: Difference between revisions

From XenWiki
Jump to navigation Jump to search
imported>Kevin
No edit summary
imported>Kevin
No edit summary
Line 21: Line 21:
*[http://www.xenbase.org/literature/article.do?articleId=6984&method=display]
*[http://www.xenbase.org/literature/article.do?articleId=6984&method=display]
*[http://www.xenbase.org/literature/article.do?articleId=45656&method=display]
*[http://www.xenbase.org/literature/article.do?articleId=45656&method=display]
*[http://www.xenbase.org/literature/article.do?articleId=48477 Atkinson-Leadbeater et al.,2015 ]
*[http://www.xenbase.org/literature/article.do?articleId=48477&method=display Atkinson-Leadbeater et al.,2015 ]


>104 Xenbase articles contain a reference to SU5402 according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso]
>104 Xenbase articles contain a reference to SU5402 according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso]
*
*
*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]]
*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]]

Revision as of 07:57, 7 January 2016

Description

"SU-5402 is a FGFR antagonist and angiogenesis inhibitor."

  • -Sigma product description
SU5402 structure, photo from Sigma-Aldrich

Genes Affected

Suppliers

Usage Notes

References

>104 Xenbase articles contain a reference to SU5402 according to textpresso